al-Shammary F J
Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Biochem Mol Biol Int. 1997 Nov;43(4):763-79. doi: 10.1080/15216549700204581.
In a retrospective study Adenosine deaminase (ADA), was assayed in 86 serum samples and 12 pleural fluid samples of patients with pulmonary tuberculosis. Serum and pleural fluid ADA levels were also examined in a group of 38 non-tuberculous patients with pleural effusion. Highly significant increases in both serum and pleural fluid ADA levels were noted in tuberculous patients when compared to both control enzyme cut-off values and non-tuberculous pleural effusion patients. Negative Ziehl-Nielsen staining for acid fast bacilli and Purified Protein Derivative skin test results were obtained in 32.3% and 11.1% of the examined patients respectively. All these patients showed significantly elevated serum or pleural fluid ADA levels. It is hereby suggested that serum and pleural fluid ADA levels can in conjunction with other tests, serve as a marker in patients of pulmonary tuberculosis.
在一项回顾性研究中,对86例肺结核患者的血清样本和12例胸腔积液样本进行了腺苷脱氨酶(ADA)检测。还对一组38例非结核性胸腔积液患者的血清和胸腔积液ADA水平进行了检测。与对照酶临界值和非结核性胸腔积液患者相比,结核患者的血清和胸腔积液ADA水平均显著升高。分别有32.3%和11.1%的受检患者抗酸杆菌萋-尼染色阴性和结核菌素皮肤试验结果为阴性。所有这些患者的血清或胸腔积液ADA水平均显著升高。据此建议,血清和胸腔积液ADA水平可与其他检查相结合,作为肺结核患者的一项标志物。